Pharmaceutical Exporter to Indonesia from India
India is a leading medicine and API supplier to Southeast Asia's largest economy. Indian Generic Medicines (IGM) exports affordable generic, branded and specialty medicines to Indonesian importers, hospitals, distributors, NGOs and pharmacies — with BPOM-aligned documentation and GDP-compliant logistics.
India–Indonesia pharmaceutical trade
Indonesia is Southeast Asia's largest economy and most populous nation, with over 282 million people. India continues to strengthen its pharmaceutical trade ties with Indonesia by supplying quality-assured medicines and active pharmaceutical ingredients. Per UN COMTRADE, Indonesia's imports of finished pharmaceutical products from India were valued at approximately US$127.4 million in 2025.
This headline figure understates India's true role. Because Indonesia imports roughly 85–90% of its pharmaceutical ingredients — mainly from India and China — India's contribution to the supply chain is far larger than finished-goods numbers suggest. India supplies not only medicines but much of the raw material that Indonesian manufacturers convert into finished products, making it central to the country's generic medicine supply.
Why Indonesia is a strategic market for Indian exporters
Demographics, healthcare reform and structural import dependence make Indonesia one of the most significant long-term opportunities for any Indian pharmaceutical exporter.
Why India is a leading pharmaceutical supplier to Indonesia
India's scale, quality accreditation and cost-effectiveness align closely with Indonesia's JKN-driven priority of affordable, accessible healthcare.
Products exported from India to Indonesia
Oncology Medicines
Advanced cancer therapies, targeted treatments, immunotherapies and monoclonal antibodies.
Diabetes Therapies
Cost-effective anti-diabetic medicines, insulin products and metabolic-care formulations.
Anti-Infectives
Quality-assured antibiotics, antivirals, antifungals and anti-parasitic medicines.
Vaccines
Temperature-controlled vaccine supply with compliant cold-chain logistics.
Nephrology Medicines
Renal-care therapies for chronic kidney disease and dialysis-related care.
Rare Disease & Specialty Biologics
Specialty medicines, biologics and biosimilars via compliant global sourcing and access pathways.
Availability of all medicinal products is subject to Indonesian regulations, BPOM registration status and applicable pharmaceutical requirements.
BPOM registration & regulatory requirements
Any medicine supplier to Indonesia from India must follow the framework administered by BPOM (Badan Pengawas Obat dan Makanan), Indonesia's National Agency of Drug and Food Control.
| Requirement | What it involves |
|---|---|
| Mandatory product registration | Registration with BPOM is required before legal distribution; samples may be requested for laboratory testing. |
| Local entity requirement | Registration must be carried out by a local Indonesian partner or licensed importer. |
| Documentation | GMP certificate, importer's permit, NPWP, industrial license, plus CPP, COA and COO. |
| Import licensing | Business Identification Number (NIB) via the OSS system, plus an entry permit (SKI) for each shipment. |
| Emerging halal certification | Phased via BPJPH; pharmaceutical implementation expected after 2026. |
| Taxes | Value Added Tax (VAT/PPN) of around 11% applies to most imported products. |
GDP-compliant export & Named Patient Programs
GDP-Aligned Handling
Good Distribution Practice handling, storage and multimodal international transport with full documentation.
Cold-Chain Management
Temperature-controlled handling for biologics, vaccines and oncology medicines, with end-to-end visibility.
Named Patient Programs
Where permitted, IGM facilitates NPP supply of unregistered oncology, specialty and rare-disease medicines.
Why Indonesian importers choose Indian Generic Medicines
Key takeaways
- India is a key pharmaceutical exporter and the leading API supplier to Indonesia, alongside China.
- Indonesia imported about US$127.4 million in finished pharmaceuticals from India in 2025; the API contribution is larger.
- Roughly 85–90% of Indonesia's pharmaceutical ingredients are imported, underlining India's strategic role.
- BPOM registration through a local entity, with GMP and import documentation, is mandatory.
- Mandatory halal certification for pharmaceuticals is an emerging requirement expected after 2026.
- IGM offers GDP-compliant export from India with complete regulatory support.
Frequently asked questions
Indian Generic Medicines (IGM) is a leading Indian pharmaceutical exporter to Indonesia, supplying generic, branded and specialty therapies to importers, hospitals and distributors with full BPOM-related documentation and regulatory support.
Indonesia imported approximately US$127.4 million in finished pharmaceutical products from India in 2025, per UN COMTRADE. India's overall contribution is larger when APIs are included, since Indonesia imports most of its raw materials.
Each product must be registered with and approved by BPOM before distribution. Registration is carried out through a local Indonesian entity and supported by a GMP certificate, importer's permit, NPWP and an industrial license for pharmaceutical products.
Yes. India is one of Indonesia's main sources of active pharmaceutical ingredients. Around 85–90% of the ingredients used by Indonesian manufacturers are imported, mainly from India and China.
Yes. India is the world's leading generic medicine supplier, offering affordable, quality-assured formulations across major therapeutic categories for the Indonesian market.
Indonesia is introducing mandatory halal certification in phases through BPJPH, with pharmaceutical implementation expected after 2026. Exporters should plan for this emerging requirement early.
Timelines vary by product and completeness of documentation. Because registration can be time-consuming, exporters are advised to begin the process well before planned shipment, working through a local partner.
Need a trusted pharmaceutical exporter to Indonesia?
For your hospital, pharmacy, importing business or distribution network — IGM supports product availability, export pricing, regulatory documentation, logistics and Indonesian BPOM import requirements.
References: UN COMTRADE / Trading Economics — Indonesia imports from India of pharmaceutical products (2025); Business-Indonesia — Indonesia pharmaceutical industry, JKN & import dependence; BPOM — drug registration requirements; BPJPH — phased halal certification; Indonesian Ministry of Trade — import licensing; India Brand Equity Foundation (IBEF) — pharmaceutical exports from India.
